Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure.

Autor: Pérez-Belmonte, Luis M.1,2,3,4 (AUTHOR) mjimeneznavarro@gmail.com, Ricci, Michele1 (AUTHOR) jaimesc25@hotmail.com, Sanz-Cánovas, Jaime1 (AUTHOR) mruiz.salud@gmail.com, Millán-Gómez, Mercedes3 (AUTHOR), Osuna-Sánchez, Julio2,5 (AUTHOR) jplara@uma.es, Ruiz-Moreno, M. Isabel1 (AUTHOR) mdlcorreo@gmail.com, Bernal-López, M. Rosa1,6 (AUTHOR) luismiguelpb1984@gmail.com, López-Carmona, María D.1 (AUTHOR), Jiménez-Navarro, Manuel4,7 (AUTHOR) jjgomezdoblas@gmail.com, Gómez-Doblas, Juan J.4,7 (AUTHOR), Lara, José P.2 (AUTHOR), Gómez-Huelgas, Ricardo1,6 (AUTHOR)
Zdroj: Journal of Clinical Medicine. Aug2021, Vol. 10 Issue 16, p3540-3540. 1p.
Databáze: Academic Search Ultimate